Skip to content

NC Quantum Apex™ H7493912420500Recalls & reported problems

Boston Scientific Corporation · PTCA Dilatation Catheter · Class 2

All models of NC Quantum Apex (48)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08714729783541), received between May 11, 2021 and May 11, 2021 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Perforation1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMay 11, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT VESSEL PERFORATION OCCURRED. THE GREATER THAN 70% STENOSED TARGET LESION WAS LOCATED IN THE MILDLY CALCIFIED AND NON-TORTUOUS LEFT ANTERIOR DESCENDING ARTERY (LAD). FOLLOWING DEPLOYMENT OF A 28MM X 4.50MM SYNERGY XD DRUG-ELUTING STENT AND POST DILATION WITH A 20MM X 5.00MM NC QUANTUM APEX BALLOON CATHETER, A VESSEL PERFORATION WAS NOTED IN THE LAD. THE PERFORATION WAS COVERED WITH A STENT AND PERICARDIOCENTESIS WAS PERFORMED. THE PATIENT WAS STABLE POST-PROCEDURE.

    Patient problems: Perforation

    MAUDE report 11810293 ↗

Other Catheters, transluminal coronary angioplasty, percutaneous devices

All Catheters, transluminal coronary angioplasty, percutaneous devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page